Blood‐based testing is an ideal non‐invasive diagnostic method, such as serum markers carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA21‐1) can help diagnose early lung cancer. This evidence concerns the gene CEACAM5 and lung carcinoma.